Amylyx Pharmaceuticals (AMLX) Tax Provisions (2022 - 2025)

Amylyx Pharmaceuticals' Tax Provisions history runs 4 years deep, the most recent figure standing at $46000.0 for Q4 2025.

• In Q4 2025, Tax Provisions rose 105.36% year-over-year to $46000.0; the TTM figure through Dec 2025 stood at $46000.0 (up 107.46% YoY), while the FY2025 annual figure was $46000.0, up 107.46% from the prior year.
• Tax Provisions was $46000.0 for Q4 2025 at Amylyx Pharmaceuticals, up from -$859000.0 in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $1.9 million in Q2 2023 to a low of -$859000.0 in Q4 2024.
• Historically, Tax Provisions has averaged $477727.3 across 4 years, with a median of $200000.0 in 2022.
• Biggest YoY gain for Tax Provisions was 1314.4% in 2023; the steepest drop was 216.44% in 2023.
• A 4-year view of Tax Provisions shows it stood at $579000.0 in 2022, then jumped by 201.38% to $1.7 million in 2023, then sank by 149.23% to -$859000.0 in 2024, then soared by 105.36% to $46000.0 in 2025.
• The last three Tax Provisions figures came in at $46000.0 (Q4 2025), -$859000.0 (Q4 2024), and $242000.0 (Q1 2024), per Business Quant data.